These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 15154632
1. Galectin-3 immunodetection may improve cytological diagnosis of occult papillary thyroid carcinoma. Pisani T, Vecchione A, Giovagnolii MR. Anticancer Res; 2004; 24(2C):1111-2. PubMed ID: 15154632 [Abstract] [Full Text] [Related]
2. Galectin-3 is not useful in thyroid FNA. Mills LJ, Poller DN, Yiangou C. Cytopathology; 2005 Jun; 16(3):132-8. PubMed ID: 15924608 [Abstract] [Full Text] [Related]
3. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms. Aron M, Kapila K, Verma K. Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889 [Abstract] [Full Text] [Related]
4. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma]. Ouyang D, Chen FJ, Wei MW, Yang AK, Chen ZQ, Li QL, Chen YF. Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965 [Abstract] [Full Text] [Related]
5. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma. Coli A, Bigotti G, Parente P, Federico F, Castri F, Massi G. J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102 [Abstract] [Full Text] [Related]
10. Galectin-3 expression in papillary microcarcinoma of the thyroid. Cvejic D, Savin S, Petrovic I, Paunovic I, Tatic S, Krgovic K, Havelka M. Histopathology; 2005 Aug; 47(2):209-14. PubMed ID: 16045783 [Abstract] [Full Text] [Related]
11. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators. Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS. Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527 [Abstract] [Full Text] [Related]